Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Meta Platforms Stock Analysis 2025–2026: AI Investment Surge, Advertising Growth, and Financial Outlook

Meta Platforms entered 2026 following a year of robust financial expansion. In the fourth quarter of 2025, total revenue reached $58.9 billion, representing a 25% year-over-year increase. Advertising remained the dominant contributor, with Family of Apps ad revenue of $58.1 billion, up 24% (23% …

Vinay Lochav | 02 March 2026

Xponential Fitness (NYSE:XPOF) Crashes 47% — Structural Breakdown or Capitulation Opportunity?

Xponential Fitness (NYSE:XPOF) plunged 47.08% to $4.26 on February 27, 206, wiping out nearly half itsmarket capitalizationin one session, with volume crossing 1.02 million shares and indicating aggressive institutional selling rather than retail-drivenvolatility.

Aditi Sarkar | 02 March 2026

PAR Technology (NYSE:PAR) Drops 27% as SaaS Growth Concerns Hit Market Sentiment

PAR Technology (NYSE:PAR) dropped 27.03% to $16.39 on February 27, 2026, as investors reacted to concerns over slowing growth in the restaurant SaaS sector.

Aditi Sarkar | 02 March 2026

LiveWire Group (NYSE: LVWR) Slides 28% — EV Motorcycle Demand Under Scrutiny

LiveWire Group (NYSE:LVWR) fell 28.21% to $1.68 on February 27, 2026, signaling deep skepticism toward EV motorcycle demand and scale economics.

Aditi Sarkar | 02 March 2026

Emergent BioSolutions (NYSE: EBS) Falls 26% — Post-Pandemic Revenue Normalization

Emergent BioSolutions (NYSE:EBS) fell 26.58% to $8.15 as investors responded to ongoing post-pandemicrevenuenormalization. The decline reflects reduced demand for pandemic-related products, highlighting the company’s exposure to fluctuations in vaccine sales and government contracts.

Aditi Sarkar | 02 March 2026

Ginkgo Bioworks (NYSE:DNA) Falls 30% — Growth Narrative Reset in Synthetic Biology

Ginkgo Bioworks (NYSE:DNA) declined 30.48% to $6.75 on February 27, 2026 with heavy selling pressure reflecting a repricing of long-duration biotech growth stocks and volume exceeding 3M shares, indicating broad participation.

Aditi Sarkar | 02 March 2026

Oil’s Sharpest Move Since Pandemic Era as Geopolitical Risk Reprices Energy Markets

At the start of March 2026, that structural relevance was abruptly reaffirmed. West Texas Intermediate (WTI) crude oil surged to around $72.53, sharply higher from the prior close of $67.28. The move represents the most pronounced single-session percentage rise in roughly four years.

Nitish Kishor | 02 March 2026

Why NVIDIA Stock Fell Despite Strong Earnings?

NVIDIA’s recent stock market decline was less about operational weakness and more about valuation sensitivity. After an extended rally driven by artificial intelligence infrastructure demand, the company’s forward earnings multiple had expanded well above historical averages.

Nitish Kishor | 27 February 2026

Dell Shares Jump 11% in Premarket on AI Server Forecast

Shares of Dell Technologies climbed 11% in premarket trading after management forecast that AI server revenue would rise 103% to roughly $50 billion by fiscal 2027. The move positions the stock for its strongest opening in over two months and reframes the company’s growth …

Nitish Kishor | 27 February 2026

US Energy Markets at an Inflection Point: Policy Shifts, Supply Constraints, and the Quiet Equity Winners

For nearly 15 years, US electricity consumption was broadly flat. Efficiency gains, industrial restructuring, and moderate economic expansion kept total load growth subdued between 2005 and 2020.

Nitish Kishor | 27 February 2026
Support

Hi! How can we help you today?

Loading…